Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating an oral once-daily two-drug HIV regimen versus a three-drug regimen in adults with no prior antiretroviral therapy, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV, HIV Infections | Phase 3 | Status: ACTIVE_NOT_RECRUITING